243590
Potassium perrhenate
99%
Synonym(s):
Potassium oxido(trioxo)rhenium, Potassium tetraoxorhenate(1-)
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
KReO4
CAS Number:
Molecular Weight:
289.30
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
233-953-8
MDL number:
Assay:
99%
Form:
powder
InChI key
QFKRWIFGDGKWLM-UHFFFAOYSA-N
InChI
1S/K.4O.Re/q+1;;;;-1;
SMILES string
[K+].[O-][Re](=O)(=O)=O
assay
99%
form
powder
reaction suitability
core: potassium
refractive index
n20/D 1.643 (lit.)
mp
550 °C (lit.)
density
4.887 g/mL at 25 °C (lit.)
Quality Level
Looking for similar products? Visit Product Comparison Guide
Related Categories
Application
The reduction of KReO4 in the preparation of cyclopentadienyltricarbonylrhenium complexes has potential as a model for the syntheses of technetium and rhenium organometallic radiopharmaceuticals.
Storage Class
5.1B - Oxidizing hazardous materials
wgk
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Spradau, T.W. Katzenellenbogen, J.A.
Organometallics, 17, 2009-2009 (1998)
Yuee Feng et al.
Inorganic chemistry, 48(23), 11058-11066 (2009-11-06)
The detailed syntheses of complexes of the form [Re(O)(X)(RNCH(2)CH(2))(2)N(Me)] (X = Me, Cl, I, R = mesityl, C(6)F(5)), 1-3, incorporating diamidoamine ancillary ligands are described. X-ray crystal structures for the complexes [Re(O)(Me)((C(6)F(5))NCH(2)CH(2))(2)N(Me)], 1a, [Re(O)(I)((C(6)F(5))N CH(2)CH(2))(2)N(Me)], 3a, and [Re(O)(I)((Mes)NCH(2))(2)N(Me)], 3b, are
Olesya A Nikonova et al.
Langmuir : the ACS journal of surfaces and colloids, 27(18), 11622-11628 (2011-08-13)
The use of an inorganic perrhenate ligand in the structure of early-transition-metal alkoxide precursors permits to achieve uniform self-assembly of the primary nanoparticles produced by their hydrolysis. The latter has been carried out in a hydrocarbon reaction medium by the
Amanda J Weeks et al.
Nuclear medicine communications, 32(2), 98-105 (2010-11-19)
Accumulation of iodide and other substrates via the human sodium/iodide symporter (hNIS) is fundamental to imaging and therapy of thyroid disease, hNIS reporter gene imaging and hNIS-mediated gene therapy. There is no readily available positron emission tomography (PET) tracer for
New sequencing technique produces high-resolution map of 5-hydroxymethylcytosine.
Jonathan Wilkinson
Epigenomics, 4(3), 249-249 (2012-08-10)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service